Healthy cells differentiated with protocol A, and ALS cells differentiated with protocol A’ presented significantly less amplification cycles for NTRK3 and therefore higher genetic expression (Fig. S2). The gene discussed is NTRK3; the disease is amyotrophic lateral sclerosis.